ISIS 3521/CGP64128A antisense blocker of tyrosine kinase C-alpha: Phase II Update

Isis Pharmaceuticals Inc. (ISIP), Carlsbad, Calif.
Product:

Read the full 77 word article

How to gain access

Continue reading with a
two-week free trial.